Trial · NCT02928900

Patient Actor Training to Improve HIV Services for Adolescents in Kenya

NCT02928900, Not applicable, Completed, University of Washington; results first posted 2024-12-09

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Patient Actor Training to Improve HIV Services for Adolescents in Kenya. Trials, record NCT02928900. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02928900

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Patient Actor Training to Improve HIV Services for Adolescents in Kenya
NCT number: NCT02928900
Status: Completed
Phases: Not applicable
Enrollment: 24 participants, actual
Lead sponsor: University of Washington
Conditions: HIV/AIDS
Interventions: Clinician training intervention
First posted: 2016-10-10
Last updated: 2024-12-09
Results first posted: 2024-12-09
Limitations and caveats: Data collection was suspended after Wave 4 training in March 2020 due to the COVID-19 pandemic

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Retention in HIV Care	Up to four years after baseline	The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for \>90 days since last visit, with no record of death or transfer).
Secondary	Proportion of HCWs With Pass/Fail Scores	Up to one month after last day of training	The proportion of HCW participants who achieved competency upon completion of the training.
Secondary	Numeric Scores From SP Actors	Up to one week after last day of training	All SP actors will complete a check-list to provide non-technical feedback to each HCW participant. Scores will be used to compute the overall pass/fail score at completion of the training.
Secondary	Health Care Worker Competency	Baseline and every nine months for up to four years	This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.
Secondary	Health Care Workers' Satisfaction With Skills	Baseline and every nine months for up to four years	This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey. These surveys will be conducted at baseline, and every nine months at the end of the training in each wave. Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.
Secondary	Adolescent Patients' Satisfaction With Care	Baseline and every nine months for up to four years	This outcome is defined as mean change in satisfaction score between intervention and control periods, using a structured survey.
Secondary	Retention in HIV Care (Secondary)	Baseline and every nine months for up to four years	A secondary measure of retention in HIV care is return for any follow-up visit within 3 months (90 days) among currently enrolled HIV-positive adolescent patients
Other	Antiretroviral (ART) Adherence in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of visits with ART refills within 1 week of scheduled visit between intervention and control periods using available electronic medical record (EMR) data.
Other	Viral Load in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in viral load between intervention and control periods using available EMR data.
Other	Linkage to Adolescent Friendly Services in HIV-positive Adolescents	Baseline and every nine months for up to four years	This measure is defined as change in the proportion of visits with referrals to affiliated services (e.g. family planning) between intervention and control periods using available EMR data.

1 to 10 of 12Source ClinicalTrials.gov

See all 12 registered outcomes

Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Retention in HIV Care	Up to four years after baseline	Medical record review. Final analysis accounts for clustering by facility, time (stepped wedge design), and newly enrolled in care status.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Proportion of HCWs With Pass/Fail Scores	Up to one month after last day of training
SECONDARY	Numeric Scores From SP Actors	Up to one week after last day of training
SECONDARY	Health Care Worker Competency	Baseline and every nine months for up to four years
SECONDARY	Health Care Workers' Satisfaction With Skills	Baseline and every nine months for up to four years
SECONDARY	Adolescent Patients' Satisfaction With Care	Baseline and every nine months for up to four years
SECONDARY	Retention in HIV Care (Secondary)	Baseline and every nine months for up to four years
OTHER_PRE_SPECIFIED	Antiretroviral (ART) Adherence in HIV-positive Adolescents	Baseline and every nine months for up to four years
OTHER_PRE_SPECIFIED	Viral Load in HIV-positive Adolescents	Baseline and every nine months for up to four years
OTHER_PRE_SPECIFIED	Linkage to Adolescent Friendly Services in HIV-positive Adolescents	Baseline and every nine months for up to four years

1 to 10 of 12Source ClinicalTrials.gov

See all 12 outcomes

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units
Retention in HIV Care	Adolescent Records - Intervention Exposed		1570		Participants
Retention in HIV Care	Adolescent Records - Unexposed		1855		Participants

Source ClinicalTrials.gov

Participant flow30

How many started, completed or left each group, period by period.

Period	Milestone	Group	Units counted
Baseline	STARTED	Standardized Patient Training	0
Baseline	STARTED	Control	24
Baseline	COMPLETED	Standardized Patient Training	0
Baseline	COMPLETED	Control	24
Baseline	NOT COMPLETED	Standardized Patient Training	0
Baseline	NOT COMPLETED	Control	0
Wave 1	STARTED	Standardized Patient Training	6
Wave 1	STARTED	Control	18
Wave 1	COMPLETED	Standardized Patient Training	6
Wave 1	COMPLETED	Control	18

1 to 10 of 30Source ClinicalTrials.gov

See all 30 participant flow

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

Total	Group	At risk
Total, all-cause mortality	SP Training Intervention	2,123
Total, all-cause mortality	No Training Intervention	2,472
Total, other adverse events	SP Training Intervention	2,123
Total, other adverse events	No Training Intervention	2,472
Total, serious adverse events	SP Training Intervention	2,123
Total, serious adverse events	No Training Intervention	2,472

Source ClinicalTrials.gov

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
29282109	DERIVED	PubMed
34939987	DERIVED	PubMed
37074998	DERIVED	PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison	Source
Adolescent Records - Intervention Exposed vs Adolescent Records - Unexposed: Retention in HIV Care	Trial comparisons
SP Training Intervention vs No Training Intervention: deaths from any cause	Trial comparisons
SP Training Intervention vs No Training Intervention: serious adverse events	Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02928900

GET https://conductscience.org/api/trials/v1/NCT02928900/flow?page=2

API reference For AI assistants